Back to search
Cannabis Hyperemesis Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cannabis Hyperemesis Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Cannabis Hyperemesis Syndrome trials you may qualify forThe aim of the study is to identify which medication (haloperidol or olanzapine) is most effective in treating nausea and abdominal pain associated with cannabi…
Cannabinoid hyperemesis syndrome (CHS) is characterized by incoercible abdominal pain and vomiting in patients with chronic cannabis use. Patients are relieved…
This is an analytical validation observational cohort study is designed to provide evidence of: safety and reliability of Body Surface Gastric Mapping using the…
The purpose of this study is to compare two commonly used agents for the treatment of cyclic vomiting to see if one agent is inferior to the other in time to im…
This study aims to determine if capsaicin cream offers symptomatic relief to patients suffering from Cannabinoid Hyperemesis Syndrome (condition that leads to r…